Claudia Giambartolomei's interest lies in finding new ways of integrating large-scale genomic data to improve our understanding of the molecular mechanisms leading to differences in phenotypes and disease risk in human biology. She completed her Ph.D. in genomics of complex diseases at the University College of London, and has specialized on integrative methodologies in psychiatric disorders as a postdoctoral fellow at Mount Sinai Icahn School of Medicine and later on in Pasaniuc's lab at the University of California, Los Angeles.
Dr Flávia Sousa received her MSc in Pharmaceutical Sciences and her PhD in Biomedical Sciences at ICBAS, University of Porto. Before joining the MINDED programme, she carried out her post-doctoral training in the laboratories of Prof. Molly Stevens at Imperial College London and with Prof. Bruno Sarmento at I3S, University of Porto. Her research interests are related to the nanomedicine field, where she has built a solid foundation in nanobiomaterials-based delivery systems for a controlled release of biomacromolecules (monoclonal antibodies, proteins, peptides). Dr Flávia Sousa is an invited assistant professor at IUCS (Gandra, Portugal) and she belongs to the board of CRS Focus group in nanomedicine and nanoscale delivery as Trainee Representative.